SecBot SecBot
Insider Cluster (4 insiders) ·Filed Mar 19, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 4/10
Horizondays Processed7mo ago
Insider cluster: 5 insiders, $1.2M total
Actionable Insight • Neutral

The activity is consistent with routine option exercise and tax-related or planned sales rather than negative sentiment; monitor for further sales or commentary in upcoming filings. No material financial impact expected.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$524.28
T+0 close · Mar 19, 2026 · via day close
Latest settled
+4.58%
T+60 · $548.27
Vs SPY
−11.11%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 20 $524.28entry
  2. T+1 · 8mo ago −0.58%α −1.63% · $521.22
  3. T+5 · 8mo ago −0.28%α +1.96% · $522.83
  4. T+20 · 7mo ago +9.38%α +0.10% · $573.44
  5. T+60 · 5mo ago +4.58%α −11.11% · $548.27
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

United Therapeutics insiders, including CEO Martine Rothblatt and CFO James Edgemond, conducted a series of derivative exercises and open-market sales over the past week. The total open-market sales amounted to approximately $1.07 million, with the majority tied to option exercises at low strike prices, indicating planned equity realization rather than reactive selling.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
4

Key Facts

  • CEO Martine Rothblatt sold 559 shares for $373,765 across multiple transactions at prices between $516.84 and $536.97.
  • CFO James Edgemond sold 991 shares for $527,236; also exercised 20,000 derivative shares (10,000 at $135.42, 10,000 at $0).
  • Director Tommy Thompson sold 275 shares for $147,845 and exercised 4,000 derivative shares.
  • Director Judy Olian sold 200 shares for $106,000.
  • Total open-market sales: $1,073,360; total derivative exercises: over $5.7 million in non-cash transactions.
  • All sales represent a tiny fraction (0.0046%) of United Therapeutics' $23.3B market cap.

Financial Impact

$1.07 million in open-market sales and over $5.7 million in derivative exercises over 7 days

insider ownershipshare countdilution

Risk Factors

  • Perception of insider selling could weigh on sentiment if misinterpreted.
  • Future sales could increase if insiders continue exercising options.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (20 trades, 7d window)cluster-UTHR-1774643538723

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 27, 2026